These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17914911)

  • 1. Highlights of the third international workshop on HIV and hepatitis coinfection.
    Vogel M; Rockstroh J
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):769-71. PubMed ID: 17914911
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of GB virus C infection in hepatitis C virus/HIV coinfection?
    Berzsenyi MD; Roberts SK
    J Infect Dis; 2006 Aug; 194(4):407-9. PubMed ID: 16845622
    [No Abstract]   [Full Text] [Related]  

  • 3. Special considerations and treatment of patients with HBV-HIV coinfection.
    Dieterich DT
    Antivir Ther; 2007; 12 Suppl 3():H43-51. PubMed ID: 18284182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapies for HIV and viral hepatitis coinfection.
    Cooper CL
    Expert Rev Anti Infect Ther; 2005 Feb; 3(1):81-9. PubMed ID: 15757459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of hepatitis C in HIV-coinfection.
    Rockstroh JK; Vogel M
    Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges for hepatitis C patients coinfected with HIV.
    Bruno R; Cotler S; Sacchi P; Ciappina V; Rondanelli M; Filice G
    Am Clin Lab; 2002 Apr; 21(3):26-31. PubMed ID: 12038082
    [No Abstract]   [Full Text] [Related]  

  • 8. HAART and Liver: a discussion of hepatic disease in those living with HIV. Interview by Paul C Adams.
    Cooper C
    Can J Gastroenterol; 2008 Dec; 22(12):973-5. PubMed ID: 19096734
    [No Abstract]   [Full Text] [Related]  

  • 9. Management issues in patients coinfected with hepatitis C virus and HIV.
    Bonacini M
    AIDS Read; 2002 Jan; 12(1):19-21, 24-6. PubMed ID: 11862656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of HIV on HCV, GBV-C/HGV, and HBV infection].
    Hayashi K; Toyoda H; Nakano I; Fukuda Y; Takamatsu J
    Nihon Rinsho; 2002 Apr; 60(4):798-802. PubMed ID: 11968791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia.
    Toyoda H; Honda T; Katano Y; Goto H; Takamatsu J
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):645-6. PubMed ID: 16200339
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia.
    Diong C; Raboud J; Li M; Cooper C;
    HIV Med; 2011 Aug; 12(7):403-11. PubMed ID: 21244600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.
    Pramoolsinsap C; Sirikulchayanonta V; Busakorn W; Poovorawan Y; Hirsch P; Theamboonlers A; Lerdverasirikul P
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):741-9. PubMed ID: 10928369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of HIV-HCV and HBV-HCV co-infection].
    Jmelnitzky AC; Jorge O; Manero E
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
    [No Abstract]   [Full Text] [Related]  

  • 16. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
    J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient.
    Béguelin C; Vazquez M; Moradpour D; Sahli R; Suter F; Rauch A; Wandeler G
    AIDS; 2016 Jan; 30(3):530-2. PubMed ID: 26760236
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV/HCV co-infection has treatment implications.
    Murphy MJ
    HIV Clin; 2000; 12(2):1, 5. PubMed ID: 11810826
    [No Abstract]   [Full Text] [Related]  

  • 19. GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortality.
    Tillmann HL; Patel K; McHutchison JG
    Gastroenterology; 2008 Jun; 134(7):2191; author reply 2191-2. PubMed ID: 18485905
    [No Abstract]   [Full Text] [Related]  

  • 20. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Risk factors for liver damage from HAART.
    TreatmentUpdate; 2006; 18(2):1-2. PubMed ID: 17228452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.